These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5218418)

  • 1. [Research on anti-leukocyte agglutinins in kala-azar and schistosomiasis].
    Moura HB
    Arq Cent Estud Fac Odontol UFMG (Belo Horiz); 1965; 2(2):229-30. PubMed ID: 5218418
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of anti-leishmanial serum antibody titre in Indian kala-azar.
    Sinha AN; Srivastava SN; Gupta AK; Shrama MC; Prasad LS
    J Commun Dis; 1985; 17(1 Suppl):100-6. PubMed ID: 3913693
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprophylaxis against kala-azar. III. Leucocyte migration inhibition (LMI) response in L. donovani infected Hissar strain albino mice.
    Jalees S; Jalil S; Hussain QZ; Topa PK
    J Commun Dis; 1982 Dec; 14(4):294-8. PubMed ID: 7184955
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoprophylaxis against kala-azar. I. Experimental L. donovani infection in golden hamsters.
    Jalees S; Topa PK; Sharma RR; Jaleel S; Joshi MC; Hussain QZ
    J Commun Dis; 1981 Dec; 13(4):273-80. PubMed ID: 7348725
    [No Abstract]   [Full Text] [Related]  

  • 10. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell, white cell and platelet autoantibodies in visceral leishmaniasis.
    Kager PA; van der Plas-Van Dalen C; Rees PH; Helmerhorst FM; von dem Borne AE
    Trop Geogr Med; 1984 Jun; 36(2):143-50. PubMed ID: 6474559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the inflammatory reaction in patients with hepatosplenic forms of schistosomiasis mansoni and kala-azar].
    Fernandes DJ; Rocha H
    Rev Inst Med Trop Sao Paulo; 1967; 9(3):129-34. PubMed ID: 5604164
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-kala-azar dermal leishmaniasis and borderline tuberculoid leprosy.
    Walker SL; Kahawita I
    Br J Dermatol; 2008 Feb; 158(2):417. PubMed ID: 18047513
    [No Abstract]   [Full Text] [Related]  

  • 18. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of kala-azar associated with post-kala-azar dermal leishmaniasis.
    Sen Gupta PC; Mukherjee AM
    J Indian Med Assoc; 1968 Jan; 50(1):1-5 passim. PubMed ID: 5668350
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.